Articles

For the Month of September, 2011

Clinical and Pre-clinical Applications of the Transcendental Meditation Program^® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults, 2006, Vol 2-3 Pp. 207-218

The ONTARGET Trial Programme: Facts and Lessons, 2009, Vol 5-3 Pp. 202-209

Pharmacological Treatments for Obesity-Related Hypertension, 2010, Vol 6-2 Pp. 92-99

Editorial [Hot topic:Current Hypertension Reviews, Hot Topics “Obesity, Hypertension, and the Metabolic Syndrome” (Guest Editor: Kazuko Masuo)], 2010, Vol 6-2 Pp. 72-72

Renal Artery Stenosis: Current Perspectives on Imaging and Endovascular Management, 2010, Vol 6-3 Pp. 210-221

Role of Adiponectin in Obesity, Hypertension, and Metabolic Syndrome, 2010, Vol 6-2 Pp. 110-117

Role of Renin-Angiotensin System in Vascular Endothelial Dysfunction of Pregnancy-Induced Hypertension, 2006, Vol 2-4 Pp. 311-316

Renal Artery Stenting: Efficacy and Complications, 2009, Vol 5-1 Pp. 7-12

Hypertensive Left Ventricular Hypertrophy Regression: Does It Matter?, 2008, Vol 4-4 Pp. 275-288

New Advances in Blockade of the Renin-Angiotensin System - the Role of Direct Renin Inhibition, 2010, Vol 6-4 Pp. 222-231

For the Month of August, 2011

Cardiac Remodeling and Exercise Training in Hypertension, 2011, Vol 7-1 Pp. 20-28

Renal Artery Stenosis: A Unique Disease or a Broad Spectrum of Different Diseases?, 2007, Vol 3-4 Pp. 276-283

Barker and Brenner: A Basis for Hypertension?, 2006, Vol 2-3 Pp. 179-185

Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?, 2007, Vol 3-1 Pp. 15-20

Editorial [Hot topic:Current Hypertension Reviews, Hot Topics “Obesity, Hypertension, and the Metabolic Syndrome” (Guest Editor: Kazuko Masuo)], 2010, Vol 6-2 Pp. 72-72

Effect of Leptin on Vascular Nitric Oxide and Endothelial Function, 2010, Vol 6-1 Pp. 1-7

Elevated Heart Rate, A Risk Factor and Risk Marker of Cardiovascular Disease, 2011, Vol 7-1 Pp. 29-40

Functional Cardiovascular Effects of Angiotensin Peptides: Focus on Atherosclerosis and Hypertension, 2009, Vol 5-3 Pp. 227-236

Hypertension in China: Past, Present, and Future, 2008, Vol 4-4 Pp. 241-244

Hypertension in Hemodialysis Patients, 2010, Vol 6-1 Pp. 44-54

For the Month of July, 2011

Nocturnal Hypertension and Chronic Kidney Disease, 2011, Vol 7-1 Pp. 5-8

Role of Sympathetic Nerve Activity in Obesity, Hypertension and Metabolic Syndrome, 2010, Vol 6-2 Pp. 83-91

Role of Epigenetic Regulatory Mechanisms in the Mechanism of Essential Hypertension, 2010, Vol 6-4 Pp. 282-284

Pharmacological Treatments for Obesity-Related Hypertension, 2010, Vol 6-2 Pp. 92-99

Editorial [Hot topic:Current Hypertension Reviews, Hot Topics “Obesity, Hypertension, and the Metabolic Syndrome” (Guest Editor: Kazuko Masuo)], 2010, Vol 6-2 Pp. 72-72

Effect of Leptin on Vascular Nitric Oxide and Endothelial Function, 2010, Vol 6-1 Pp. 1-7

Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction, 2008, Vol 4-4 Pp. 245-255

Functional Cardiovascular Effects of Angiotensin Peptides: Focus on Atherosclerosis and Hypertension, 2009, Vol 5-3 Pp. 227-236

Pathophysiology of Hypertension During Preeclampsia: Role of Inflammatory Cytokines, 2007, Vol 3-1 Pp. 69-74

Hyperuricemia and Hypertension — A Causal Relationship Ignored For All Too Long, 2011, Vol 7-1 Pp. 41-53